Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Artificial Intelligence-augmented analytical method development and validation in pharmaceutical manufacturing: Current applications, regulatory landscape and future directions

Breadcrumb

  • Home
  • Artificial Intelligence-augmented Analytical Method Development and Validation In Pharmaceutical Manufacturing: Current Applications, Regulatory Landscape and Future Directions
  • Artificial Intelligence-augmented analytical method development and validation in pharmaceutical manufacturing: Current applications, regulatory landscape and future directions

Adedokun Taofeek 1, *, Chiamaka Okojie 2, Emeka Nwosu 3 and Isabelle Dubois 4 

1 Department of Research, Osun State College of Technology, Esa-Oke, Nigeria.
2 Department of Environmental Science, University of Ibadan, Ibadan, Nigeria.
3 Faculty of Engineering, University of Nigeria, Nsukka, Nigeria.
4 Senior Researcher in Artificial Intelligence, Ecole Normale Superieure, Paris, France.

Review Article

GSC Biological and Pharmaceutical Sciences, 2026, 35(02), 079-088

Article DOI: 10.30574/gscbps.2026.35.2.0166

DOI url: https://doi.org/10.30574/gscbps.2026.35.2.0166

Received on 17 March 2026; revised on 02 May 2026; accepted on 05 May 2026

The pharmaceutical, biotechnology, and medical device industries are undergoing a paradigm shift as artificial intelligence (AI) and machine learning (ML) technologies are increasingly integrated into analytical method development, validation, and lifecycle management. Traditional approaches to method development, while well-established under regulatory frameworks such as ICH Q2(R2) and the recently adopted ICH Q14, are often labor-intensive, iterative, and resource-constrained. This review examines the current landscape of AI-augmented analytical method development and validation across diverse pharmaceutical modalities, including small molecules, biologics, ophthalmic emulsions, and lipid nanoparticle-based mRNA vaccine delivery systems. The paper discusses how AI and ML tools, including deep learning, predictive analytics, and computer vision, are being applied to accelerate method optimization, enhance robustness evaluation, predict method performance, and strengthen data integrity throughout the analytical procedure lifecycle. The regulatory context is explored in depth, with particular attention to the ICH Q14 enhanced approach, the analytical target profile concept, and the role of GAMP 5 and ALCOA+ principles in ensuring that AI-driven analytical workflows remain compliant and audit-ready. Key challenges, including model interpretability, validation of AI tools themselves, regulatory acceptance, and data quality, are examined alongside emerging opportunities such as multi-omics integration, generative AI for method design, and predictive bio-cyber resilience frameworks. This review concludes with a set of recommendations for researchers, regulators, and industry practitioners seeking to harness AI for next-generation analytical method development while maintaining the scientific rigor and regulatory compliance that underpin patient safety and product quality.

Analytical Method Development; Validation; Artificial Intelligence; Machine Learning; ICH Q14; ICH Q2(R2); Data Integrity; Pharmaceutical Manufacturing; Biologics; Mrna Vaccines; GAMP 5; ALCOA+; Computer Vision; Predictive Analytics

https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2026-…

Preview Article PDF

Adedokun Taofeek, Chiamaka Okojie, Emeka Nwosu and Isabelle Dubois. Artificial Intelligence-augmented analytical method development and validation in pharmaceutical manufacturing: Current applications, regulatory landscape and future directions. GSC Biological and Pharmaceutical Sciences, 2026, 35(02), 079-088. Article DOI: https://doi.org/10.30574/gscbps.2026.35.2.0166.


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution